One of their key customers CEO said "We are just getting started..."

https://youtu.be/AVY060ALTVA


Also Scomnet received Supplier of the Year 2021 Award from customer E.

Supercomnet's 4Q profit jumps 62% on higher sales, better profit margin - The Edge Markets

http://www.theedgemarkets.com/article/supercomnets-4q-profit-jumps-62-higher-sales-better-profit-margin#.YEuCOlQU_ps.whatsapp

New 4 storey building coming up, growing big!

Key customers Edwards Lifesciences announcing Q3 earnings. Mentioned in the report that relates to Scomnet is sales of Edwards' TruWave disposable pressure monitoring devices used in the ICU were lifted by a large one-time order in Europe associated with ICU capacity expansion. This is an area of Scomnet focus. With 2nd, 3rd waves coming, Scomnet will continue to benefit from this pandemic.

https://www.edwards.com/ns20201021

Should be big investor linked to Rakuten, otherwise there would not have upgraded them so quickly after a recent upgrade.

Maybe more to come.

Yes, it's a dilution, however if u recall when Scomnet announced free warrant (3 for 1 free warrant), scomnet price was adjusted down, as such current price is reflecting current state of share and warrant share. There is an excise price to pay for converting to mother share.

Disposal of shares to increase market liquidity. I believe, on the other hand, they will be converting free warrants to increase their holding stake in Scomnet. This shares disposal helps to increase shareholders benefit, ie increase liquidity, gaining access to wider investors investment.

With UOB Kay Hian coverage on Scomnet, more such deals will pop up!!

Hang on for more profit!!!

Surprise for UOB Kay Hian to cover Scomnet on their portfolio. Likely to attract big boys into Scomnet.

This quarter results will see significant increase top and bottom line from Covid related business ramp up as well as their 1st D-Clot shipment.

Why over 1.90?

Scomnet key customer Edwards Lifesciences, announced their Q2 earning results. One key highlights that influences Scomnet is "Increased demand for our TruWave disposable pressure monitoring devices used in the ICU remains strong". This is one of the key focus of Scomnet business. We should see next leap jump of their revenue in Q2

Copper price is rising all time high, that may hit into their earnings for Q2. Hope they did some hedging.

Is Q1 results releasing this week?

Allocated RM7-8 mil for capacity expansion

AR just released!! What can you expect?

Record top and bottom line!!

Lolx

This has nothing to do with Scomnet right?

https://www.theedgemarkets.com/article/aminvestment-cgscimb-uob-kay-hian-tighten-margin-financing-standards-glove-shares

More room to go!!

https://klse.i3investor.com/m/blog/httpsklsei3investorcomHE/2020-06-02-story-h1507957577-HEALTH_CARE_STOCKS_STILL_MORE_ROOM_TO_GO.jsp

When is quarter results announcement?

Scomnet in Simplywall rating

https://simplywall.st/stocks/my/capital-goods/klse-scomnet/supercomnet-technologies-berhad-shares/news/is-supercomnet-technologies-berhads-klsescomnet-latest-stock-performance-a-reflection-of-its-financial-health/

Scomnet is mentioned in today star

https://www.thestar.com.my/business/business-news/2020/05/21/balance-sheet-cashflow-matter

Accumulate!!

Any indicative target price mentioned?

Another interesting article on medical pressure sensors market size.. it's gonna grow significantly! Scomnet is producing pressure transducer devices and patients monitoring devices. Let's wait and see their quarterly results!

https://www.google.com/amp/s/markets.businessinsider.com/amp/news/medical-pressure-sensors-market-size-to-boost-owing-to-increasing-adoption-of-advanced-healthcare-equipment-by-2028-radiant-insights-inc-1029164397

Edwards Lifesciences Q1 2020 results just out from oven.

Critical Care sales were $183 million for the quarter. This performance was lifted by strong demand for the company's disposable pressure monitoring devices used in intensive care units as a result of the COVID-19 pandemic.

This confirms Scomnet production capacity surge to cope with demand. Sources indicate the volume surge is of 5x to 6x. Ready to fly!

Got news that they can run higher manpower now, production is ramping up capacity to meet demand.

Dividends announcement!!

Please be informed that the Board of Directors of SUPERCOMNET TECHNOLOGIES BERHAD has on April 17, 2020, proposed the following Dividends for the year ended December 31, 2019 to be approved by its shareholders at the forthcoming Thirtieth Annual General Meeting of the Company:-

A Special Single Tier Dividend of 0.5 sen per share; and
A Final Single Tier Dividend of 1 sen per share.
However, the entitlement date and date of payment of the aforesaid dividends have yet to be finalized at the moment.



This announcement is dated April 17, 2020.

J&J just reported their extraordinary results. Dividends increase further. This shows the resilience of medical industry in time of pandemic. There's a strong indication of Scomnet's largest customer Edwards Lifesciences growth which will boost Scomnet another record breaking revenue.

https://www.cnbc.com/2020/04/14/jj-shares-rise-after-raising-dividend-but-cutting-2020-earnings-outlook-over-coronavirus-outbreak.html

Predicting more good news coming...

Surge in new orders from Covid pandemics!

https://www.nst.com.my/business/2020/04/580881/stb-sees-surge-new-orders

They are one of the key supplier of Edwards Lifesciences and if you analyse EW business portfolio, their devices are used in critical care to monitor patients health conditions, provide realtime data to support clinicians to administer drug in ER or ICU. With global surge in EU demand (next USA) of hospital beds and fixture, every ICU or ER will need monitors and cables in tens of thousands cables. For sure, Scomnet business will benefit from this epidemic.

Seems like Scomnet is granted for essential medical production.

80% of raw material cost of cable wire is copper. Copper price has been tumbling down for the past months from USD6300 to 5500/ton and it is still coming down. For sure this lower raw material cost will boost their margin.

Key customers earning reporting, sales grew 20%

https://www.prnewswire.com/news-releases/edwards-lifesciences-reports-fourth-quarter-results-300996432.html

Coming up

https://www.thestar.com.my/business/business-news/2020/01/04/top-20-stock-picks-for-2020

If not for RM3mil amortization, profit would have been RM17mil

For the period under review , Group revenue has been increased by 48.28% (or RM29.49 million) from RM 61.08 million to RM 90.57 million whereby Supercomal Medical Product(SMP) contribute 20.61 million of the sales increment. The profit after tax increased by 40.44 % ( or RM 4.11 million) from RM 10.15 million to RM 14.26 million after the amortisation of RM 3 million intangible assets. The improvement in profit mainly due to contribution from SMP which accounted 80% of profit for the period .

Medical business is contributing 2/3 of the revenue growth.

Another good news from one of their key customers. scomnet. Edward's Lifesciences Sapien 3 TAVI receiving approval for Europe market for low risk patients. Down stream suppliers confirm will benefit from this expanded market.

https://markets.businessinsider.com/news/stocks/edwards-sapien-3-tavi-receives-expanded-approval-in-europe-1028662712

Let's see Q3 earnings results in November. Additional revenues will be coming out from their new customers. Tax exemption for new products are likely to be reflected in this quarter, that will boost the bottom line.

Fairly accurate assessment by Bursa Master. This is considering that Edwards Lifesciences is their largest customer. I read Scomnet has commercialized other medical business opportunities, these growth should be seen in their forthcoming quarterly report.

https://klse.i3investor.com/m/blog/Bursa_Master/232210.jsp

Another good quarter by Scomnet key customers Edwards Lifesciences. Sales grew 21%.

https://www.prnewswire.com/news-releases/edwards-lifesciences-reports-third-quarter-results-300944228.html

This news seems to be timed along with their Q2 reporting end Aug

Any body knows about their thrombectomy product launch? Base on their report, it's 2019.

One of their key customers quarterly earnings.. exceeds market expectations. Good news!!

https://finance.yahoo.com/news/edwards-lifesciences-ew-q2-earnings-214509921.html?.tsrc=applewf

Many medical device players have all the long avoid China due to IP. With the ongoing trade war with China, more medtech companies will avoid China further. Did a check on one of their major customers, Edwards, their GP is at 70+%, for sure the down stream suppliers will be healthy!

https://www.theedgemarkets.com/article/supercomnet-may-move-higher-says-rhb-retail-research

Now that with their key medical device customer setting operations in KL, fairly certain these medical device MNC will leverage their existing supply chain to grow, and SMP is well position to ride on this relationship.

https://www.tradingview.com/chart/0001/90vbbjgs-TradeVSA-Supercomnet-testing-resistance-with-high-volume/